| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/27/2008 | CN101129349A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 02/27/2008 | CN101129314A Health care feet soaking powder and feet soaking patch |
| 02/27/2008 | CN101129194A Process for preparing kudzu root cymarose |
| 02/27/2008 | CN101129144A Processes for preparing kudzu root flavone biscuit |
| 02/27/2008 | CN100371707C Method for measuring tepene lactone content in compositions extracted from Ginkgo biloba leaves |
| 02/27/2008 | CN100371345C Perindopril |
| 02/27/2008 | CN100371002C Chinese medicinal preparation for treating heart cerebrovascular disease and making method thereof |
| 02/27/2008 | CN100370989C Use of 5-HT5-ligands in treatment of neurodegenerative and neuropsychiatric disturbances |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/27/2008 | CN100370984C Telmisartan dispersible tablet and its preparation method |
| 02/27/2008 | CN100370978C Composition for treating hemorrhoids |
| 02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
| 02/27/2008 | CN100370973C Traditional Chinese medicinal preparation for treating obstruction of qi in the chest |
| 02/27/2008 | CN100370972C Heart boosting pulse restoring tablet and its preparation method |
| 02/27/2008 | CN100370970C Compound red-rooted salvia preparation, and its preparing method |
| 02/27/2008 | CN100370968C Quercetin long-acting liposome powder for injection and its preparing method |
| 02/26/2008 | US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 02/26/2008 | US7335722 For use in pharmaceuticals, food additivs |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335681 Inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase; Gaucher's disease, Tay Sachs disease, Fabry's disease. Sandhoff disease or GM1 gangliosidosis |
| 02/26/2008 | US7335680 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/26/2008 | US7335671 containing a 2-(hetero)aryloxazol-4-ylalkylcycloalkyl group, (2R/2S)-3-[(1R,3S)-3-(5-methyl-2-m-tolyloxazol-4-ylmethoxymethyl)-cyclohexyloxy ]-2-(4-trifluoromethylbenzyloxy)propionic acid; treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization and insulin resistance; |
| 02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 02/26/2008 | US7335655 Treating asthma with e.g. 2-(3-methoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide; potent, yet selective modulators of adenosine receptors |
| 02/26/2008 | US7335654 Phosphodiesterase 4 inhibitors |
| 02/26/2008 | US7335490 administering genetic engineered erythropoietin produced in host cells expressing EIA protein of an adenovirus, and optionally statins and angiotensin converting enzyme inhibitors; cardiovascular disorders |
| 02/26/2008 | US7335389 Beverages containing plant sterols |
| 02/26/2008 | CA2363124C Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 02/26/2008 | CA2322195C Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 02/26/2008 | CA2238553C Cholesterol-lowering composition |
| 02/26/2008 | CA2207545C Antiarrhythmic (s)-enantiomers of methanesulfonamides |
| 02/21/2008 | WO2008022171A1 Methods of using aryl sulfonyl compounds effective as soluble epoxide hydrolase inhibitors |
| 02/21/2008 | WO2008022038A1 Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure |
| 02/21/2008 | WO2008022033A2 Methods for preventing or treating cardiovascular disease |
| 02/21/2008 | WO2008021891A2 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 02/21/2008 | WO2008020962A2 Cholesterol lowering drug combination |
| 02/21/2008 | WO2008020802A1 Cardioprotective compounds |
| 02/21/2008 | WO2008020711A1 Quinazoline derivative as phosphodiesterase inhibitor and a process for preparing the same |
| 02/21/2008 | WO2008020625A1 Dibenzoylmethane compound and pharmaceutical composition comprising the compound as active ingredient |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020606A1 Antiangiogenic agent |
| 02/21/2008 | WO2008020275A1 Replacing heart surgery by micronutrient |
| 02/21/2008 | WO2008020260A2 Use of siderophores in prevention of vascular diseases, production of siderophores and qualifying siderophore containing meat-products |
| 02/21/2008 | WO2008020206A2 Fused thiophene derivatives as mek inhibitors |
| 02/21/2008 | WO2008020124A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists |
| 02/21/2008 | WO2008020119A1 Activated fibroblasts for treating tissue and/or organ damage |
| 02/21/2008 | WO2008020081A1 6-substituted isoquinoline derivatives as rock-1 inhibitors |
| 02/21/2008 | WO2008019823A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 02/21/2008 | WO2008000951A3 Urea derivatives of tropane, their preparation and their therapeutic application |
| 02/21/2008 | WO2007149568A3 N- (4-chl0r0-3-methyl-5-is0xaz0lyl) -2- [2-methyl-4, 5- (methylenedioxy) phenylacetyl] -thiophene-3-sulfonamide |
| 02/21/2008 | WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 02/21/2008 | WO2007146981A3 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
| 02/21/2008 | WO2007144501A3 Use of a vasopeptidase inhibitor for the treatment of pulmonary arterial hypertension |
| 02/21/2008 | WO2007130509A9 Pyrroloquinoline quinones and use thereof |
| 02/21/2008 | WO2007128088A3 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases |
| 02/21/2008 | WO2007121495A3 Method for diagnosing cardiovascular diseases |
| 02/21/2008 | WO2006081190A3 Compositions and methods for treating cardiac conditions |
| 02/21/2008 | US20080045709 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/21/2008 | US20080045610 Methods for regulating neurotransmitter systems by inducing counteradaptations |
| 02/21/2008 | US20080045603 Methods for treating at least one condition having MT1 receptor, 5HT2B receptor, and L-type calcium channel activity |
| 02/21/2008 | US20080045599 administering dalcetrapib with food |
| 02/21/2008 | US20080045591 (E)-7,7-Dimethyl-1-(4-hydroxy-3-methoxyphenyl)-oct-1-ene-3,5-dione; (E)-1-(4-Hydroxy-3-methoxyphenyl)-6-methyl-hept-1-ene-3,5-dione; prophylaxis of hypersensitivity, smooth muscle disorders, spasmodic conditions, allergic conditions, inflammatory conditions and/or pain |
| 02/21/2008 | US20080045581 Ppar active compounds |
| 02/21/2008 | US20080045580 Novel Isoxazole Compounds Having Ppar Agonist Activity |
| 02/21/2008 | US20080045571 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2008 | US20080045563 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
| 02/21/2008 | US20080045549 Adenosine a2b receptor antagonists |
| 02/21/2008 | US20080045541 Dihydropyridinone Derivatives |
| 02/21/2008 | US20080045540 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 02/21/2008 | US20080045531 Anti-inflammatory medicaments |
| 02/21/2008 | US20080045524 Selective NPY (Y5) antagonists |
| 02/21/2008 | US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 02/21/2008 | US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2008 | US20080045489 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2008 | US20080045460 Treatment of prostate cancer by inhibiting lyn-tyrosine kinase |
| 02/21/2008 | US20080045459 Orally administered peptides synergize statin activity |
| 02/21/2008 | US20080045444 Compositions and methods for treating cardiovascular disease and myocardial infarction with dipeptidyl peptidase inhibitors or b type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation |
| 02/21/2008 | US20080044505 Nelumbinis Semen Extract for Preventing and Treating Ischemic Heart Disease and Pharmaceutical Composition and Health Food Containing the Same |
| 02/21/2008 | US20080044495 Extract of plant Dendrobii Caulis and preparing process thereof |
| 02/21/2008 | US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin |
| 02/21/2008 | US20080044444 Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044423 Compounds |
| 02/21/2008 | US20080044404 Annexin V for Preventing Atherothrombosis and Plaque Rupture |
| 02/21/2008 | US20080044399 Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotype |
| 02/21/2008 | US20080044392 Isolation of Stem Cell-Like Cells and Use Thereof |
| 02/21/2008 | US20080044354 Compounds Containing a N-Heteroaryl Moiety Linked to Fused Ring Moieties for the Inhibition of Nad(P)H Oxidases and Platelet Activation |
| 02/21/2008 | DE202004021379U1 Kristalline Formen von Pitivastatin Calcium Crystalline forms of calcium Pitivastatin |
| 02/21/2008 | CA2691467A1 Cholesterol lowering drug combination |
| 02/21/2008 | CA2661014A1 Cardioprotective compounds |
| 02/21/2008 | CA2660903A1 Modulators of muscarinic receptors |
| 02/21/2008 | CA2660707A1 Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure |
| 02/21/2008 | CA2660489A1 6-substituted isoquinoline derivatives as rock-1 inhibitors |
| 02/21/2008 | CA2659928A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists |
| 02/20/2008 | EP1889911A2 An antisense oligonucleotide preparation method |
| 02/20/2008 | EP1889842A1 Heterocyclic compound |
| 02/20/2008 | EP1889839A1 Bicyclic compound, production and use as HIV inhibitors |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889633A1 Medicinal compositions for angiogenic therapy |